Abstract:Zhan Gu, 1, * Yan Bi, 2, * Fan Yuan, 2, * Ruirui Wang, 1 Dong Li, 3 Jianying Wang, 1 Xiaojuan Hu, 1 Guang He, 2 Lei Zhang, 1 Bao-cheng Liu 1 1 Shanghai Innovation Center of TCM Health Service, Shanghai University of Traditional Chinese Medicine, Shanghai 201203, People's Republic of China; 2 Bio-X Institutes, Key Laboratory for the Genetics of Developmental and Neuropsychiatric Disorders (Ministry of Education), Shanghai Jiao Tong University, Shanghai 200030, People's Republic of China; 3 Zhangjiang Community Health Service Center of Pudong New District, Shanghai, People's Republic of China *These authors contributed equally to this work Correspondence: Bao-cheng Liu Email baochliu@shutcm.edu.cn Background: As fat and obesity play a vital role in the pathophysiology of metabolic dysfunction-associated fatty liver disease (MAFLD), this study aims to investigate the association between the fat mass and obesity-associated gene ( FTO ) and MAFLD. Methods: Six SNPs (rs6499640, rs1421085, rs8050136, rs3751812, rs9939609 and rs9930506) within FTO were genotyped for 741 MAFLD patients (median age, 69.98; interquartile range, 66.55– 75.93) and 825 healthy people (median age, 69.94; interquartile range, 66.39– 75.64). Allele and genotype frequencies, pairwise linkage disequilibrium (LD) and haplotype analysis were calculated. Results: BMI, waist circumference, systolic blood pressure, diastolic blood pressure, fasting plasma glucose, triglyceride, alanine transaminase, glutamyl transpeptidase and the prevalence of diabetes were found to be higher in the MAFLD individuals comparing to the control ones ( P < 0.05). For rs1421085, the C allele frequency was remarkably higher in MAFLD after Bonferroni correction (OR [95% CI] =1.353 [1.095– 1.671]; P corr =0.030), and a significantly different genotype result was observed in log-additive model (OR [95% CI] =1.369 [1.108– 1.691]; P corr =0.024). For rs8050136, significantly increased A allele frequency was observed in MAFLD (OR [95% CI] =1.371 [1.109– 1.695]; P corr =0.024), and A-allele carriers showed increased MAFLD risk (OR [95% CI] =1.393 [1.103– 1.759]; P corr =0.030). For rs3751812, the T allele frequency was remarkably higher in MAFLD (OR [95% CI] =1.369 [1.108– 1.691]; P corr =0.024), and T-allele carriers demonstrated high MAFLD risk (OR [95% CI] =1.392 [1.103– 1.756]; P corr =0.030). For rs9939609, A allele frequency was also remarkably high in MAFLD (OR [95% CI] =1.369 [1.108– 1.691]; P corr =0.024), and A-allele carriers were more susceptible to MAFLD (OR [95% CI] =[1.103– 1.756]; P corr =0.030). A strong LD was found among rs1421085, rs8050136, rs3751812 and rs9939609 (r 2 > 0.8), and individuals with C-A-T-A haplotype had an elevated MAFLD risk (P =0.005). Conclusion: The case-control study indicated that C variant of rs1421085, A variant of rs8050136, T variant of rs3751812 and A variant of rs9939609 are associated with elevated MAFLD risk in the older Chinese Han population. Keywords: MAFLD, FTO , polymorphism, genetic association, susceptibility

Genetic variants associated with metabolic dysfunction‐associated fatty liver disease in western China

Genome-wide association study of metabolic dysfunction-associated fatty liver disease in a Korean population

The Regulation Effect of GLUT9/SLC2A9 on Intrahepatic Uric Acid Level and Metabolic Associated Fatty Liver Disease

FTO Polymorphisms are Associated with Metabolic Dysfunction-Associated Fatty Liver Disease (MAFLD) Susceptibility in the Older Chinese Han Population

NAFLD‐related gene polymorphisms and all‐cause and cause‐specific mortality in an Asian population: the Shanghai Changfeng Study

Gwas-Identified Common Variants with Nonalcoholic Fatty Liver Disease in Chinese Children

Genetic Variants at PSMD3 Interact with Dietary Fat and Carbohydrate to Modulate Insulin Resistance

I148M variant of PNPLA3 increases the susceptibility to non-alcoholic fatty liver disease caused by obesity and metabolic disorders

Polyunsaturated Fatty Acids Modulate the Association Between PIK3CA-KCNMB3 Genetic Variants and Insulin Resistance

The PNPLA3 Rs738409 C>G Variant Influences the Association Between Low Skeletal Muscle Mass and NAFLD: the Shanghai Changfeng Study

The Health Impact of MAFLD, a Novel Disease Cluster of NAFLD, is Amplified by the Integrated Effect of Fatty Liver Disease-Related Genetic Variants

The PNPLA3 rs738409 C>G variant interacts with changes in body weight over time to aggravate liver steatosis, but reduces the risk of incident type 2 diabetes

A Single Nucleotide Polymorphism in the FADS1 Gene is Associated with Plasma Fatty Acid and Lipid Profiles and Might Explain Gender Difference in Body Fat Distribution

Genetic Variation in the GCKR Gene is Associated with Non-Alcoholic Fatty Liver Disease in Chinese People

Effects of Genetic Variants on Lipid Parameters and Dyslipidemia in A Chinese Population

The association between rs1260326 with the risk of NAFLD and the mediation effect of triglyceride on NAFLD in the elderly Chinese Han population

A multi-ethnic study of a PNPLA3 gene variant and its association with disease severity in non-alcoholic fatty liver disease

Genetic Variant I148M in PNPLA3 is Associated with the Ultrasonography-Determined Steatosis Degree in a Chinese Population.

Genetic Polymorphism of Vitamin D Family Genes <i>CYP2R1</i>, <i>CYP24A1</i>, and <i>CYP27B1</i> Are Associated With a High Risk of Non-alcoholic Fatty Liver Disease: A Case-Control Study

Relevance of PNPLA3, TM6SF2, HSD17B13, and GCKR Variants to MASLD Severity in an Egyptian Population

SAMM50-rs2073082, -rs738491 and -rs3761472 Interactions Enhancement of Susceptibility to Non-Alcoholic Fatty Liver Disease